Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: A randomised, double-blind, placebo-controlled trial

The Lancet

Volumn 376, Issue 9741, 2010, Pages 606-614

  Armah, George E ^a   Sow, Samba O ^c   Breiman, Robert F ^d,e   Dallas, Michael J ^f   Tapia, Milagritos D ^c,g   Feikin, Daniel R ^d,e   Binka, Fred N ^b   Steele, A Duncan ^h   Laserson, Kayla F ^d,e   Ansah, Nana A ⁱ   Levine, Myron M ^g   Lewis, Kristen ^j   Coia, Michele L ^f   Attah Poku, Margaret ^a   Ojwando, Joel ^d,e   Rivers, Stephen B ^f   Victor, John C ^j   Nyambane, Geoffrey ^d,e   Hodgson, Abraham ⁱ   Schödel, Florian ^f   Ciarlet, Max ^f   Neuzil, Kathleen M ^j   more..

^a University of Ghana   (Ghana)

^b UNIVERSITY OF GHANA   (Ghana)

^c Center for Vaccine Development   (Mali)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^f MERCK RESEARCH LABORATORIES   (United States)

^g University of Maryland School of Medicine Center for Vaccine Development   (United States)

^h WORLD HEALTH ORGANIZATION   (Switzerland)

ⁱ NAVRONGO HEALTH RESEARCH CENTRE   (Ghana)

^j PATH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; ROTAVIRUS VACCINE; IMMUNOGLOBULIN A; LIVE VACCINE; VIRUS ANTIBODY;

AFRICA; ARTICLE; BRONCHIOLITIS; BRONCHOPNEUMONIA; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVELOPING COUNTRY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENZYME IMMUNOASSAY; FEMALE; FEVER; FOLLOW UP; GASTROENTERITIS; GASTROINTESTINAL SYMPTOM; GHANA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INCIDENCE; INFANT; KENYA; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALARIA; MALE; MALI; MULTICENTER STUDY; OTITIS MEDIA; OUTCOME ASSESSMENT; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ROTAVIRUS INFECTION; RURAL AREA; SCORING SYSTEM; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; URBAN AREA; VOMITING; WORLD HEALTH ORGANIZATION; AFRICA SOUTH OF THE SAHARA; BLOOD; IMMUNIZATION; IMMUNOLOGY; ORAL DRUG ADMINISTRATION; ROTAVIRUS; ROTAVIRUS INFECTIONS; SEVERITY OF ILLNESS INDEX; VIROLOGY;

ADMINISTRATION, ORAL; AFRICA SOUTH OF THE SAHARA; ANTIBODIES, VIRAL; DEVELOPING COUNTRIES; DOUBLE-BLIND METHOD; GASTROENTERITIS; HUMANS; IMMUNIZATION SCHEDULE; IMMUNOGLOBULIN A; INFANT; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SEVERITY OF ILLNESS INDEX; VACCINES, ATTENUATED;

EID: 77956063814     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60889-6     Document Type: Article

References (38)

1. C Boschi-Pinto, L Velebit, K Shibuya Estimating child mortality due to diarrhoea in developing countries Bull World Health Organ 86 2008 710 717
2. RE Black, S Cousens, HL Johnson Global, regional, and national causes of child mortality in 2008: a systematic analysis Lancet 375 2010 1969 1987
3. CL Fischer Walker, O Fontaine, MW Young Zinc and low osmolarity oral rehydration salts for diarrhoea: a renewed call to action Bull World Health Organ 87 2009 780 786
4. WHO Global networks for surveillance of rotavirus gastroenteritis, 2001-2008 Wkly Epidemiol Rec 83 2008 421 425
5. UD Parashar, A Burton, C Lanata Global mortality associated with rotavirus disease among children in 2004 J Infect Dis 200 2009 S9 S15
6. WHO Rotavirus vaccines Wkly Epidemiol Rec 82 2007 285 295
7. WHO Conclusions and recommendations from the Strategic Advisory Group of Experts to the Department of Immunization, Vaccines, and Biologicals Wkly Epidemiol Rec 81 2006 2 12
8. K Zaman, DD Anh, JC Victor Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial Lancet 2010 10.1016/S0140-6736(10)60755-6 publsihed online Aug 6.
9. MJ Gilchrist, TS Bretl, K Moultney Comparison of seven kits for detection of rotavirus in fecal specimens with a sensitive, specific enzyme immunoassay Diagn Microbiol Infect Dis 8 1987 221 228
10. DJ DiStefano, N Kraiouchkine, L Mallette Novel rotavirus VP7 typing assay using a one-step reverse transcriptase PCR protocol and product sequencing and utility of the assay for epidemiological studies and strain characterization, including serotype subgroup analysis J Clin Microbiol 43 2005 5876 5880
11. T Vesikari, DO Matson, P Dennehy Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine N Engl J Med 354 2006 23 33 (Pubitemid 43048948)
12. M Ciarlet, R Sani-Grosso, G Yuan Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine Pediatr Infect Dis J 27 2008 874 880
13. T Ruuska, T Vesikari Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes Scand J Infect Dis 22 1990 259 267
14. T Ruuska, T Vesikari A prospective study of acute diarrhoea in Finnish children from birth to 2 1/2 years of age Acta Paediatr Scand 80 1991 500 507
15. HF Clark, FE Borian, LM Bell Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season J Infect Dis 158 1988 570 587
16. O Miettinen, M Nurminen Comparative analysis of two rates Stat Med 4 1985 213 226
17. WHO Evaluating clinical trial data and guiding future research for rotavirus vaccines Wkly Epidemiol Rec 83 2008 385 388
18. SA Madhi, NA Cunliffe, D Steele Effect of human rotavirus vaccine on severe diarrhea in African infants N Engl J Med 362 2010 289 298
19. SL Block, T Vesikari, MG Goveia Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life Pediatrics 119 2007 11 18
20. T Vesikari, R Itzler, DO Matson Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization across three regions (11 countries) Int J Infect Dis 11 2007 S29 S35
21. M Ciarlet, F Schödel Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq® Vaccine 27 2009 G72 G81
22. TJ John Antibody response of infants in tropics to five doses of oral polio vaccine BMJ 1 1976 812
23. Suharyono C Simanjuntak, N Witham Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children Lancet 340 1992 689 694
24. ZM Rodriguez, MG Goveia, JE Stek Concomitant use of an oral live pentavalent human-bovine reassortant rotavirus vaccine with licensed parenteral pediatric vaccines in the United States Pediatr Infect Dis J 26 2007 221 227
25. C Siegrist Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants Vaccine 21 2003 3406 3412
26. Steele AD, Reynders J, Scholtz F, et al. Comparison of two different regimens (two doses versus three doses) in terms of reactogenicity, safety and immunogenicity of the live attenuated oral rotavirus vaccine RIX4414 co-administered with oral polio vaccine in South African infants. J Infect Dis (in press).
27. K Zaman, DA Sack, M Yunus Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age Vaccine 27 2009 1333 1339
28. DI Bernstein, VE Smith, DS Sander Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants J Infect Dis 162 1990 1055 1062
29. H Brussow, O Benitez, F Uribe Rotavirus-inhibitory activity in serial milk samples from Mexican women and rotavirus infections in their children during their first year of life J Clin Microbiol 31 1993 593 597
30. RI Glass, DJ Ing, BJ Stoll Immune response to rotavirus vaccines among breast-fed and nonbreast-fed children Adv Exp Med Biol 310 1991 249 254
31. M Patel, AL Shane, UD Parashar Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis 200 2009 S39 S48
32. AA Ellisa, P Wincha, Z Daoub Home management of childhood diarrhoea in southern Mali - implications for the introduction of zinc treatment Soc Sci Med 64 2007 701 712
33. Centers for Disease Control and Prevention Delayed onset and diminished magnitude of rotavirus activity - United States, November 2007-May 2008 MMWR Morb Mortal Wkly Rep 57 2008 697 700
34. HG Chang, PF Smith, B Tserenpuntsag Reduction in hospitalizations for diarrhea and rotavirus infections in New York state following introduction of rotavirus vaccine Vaccine 28 2010 754 758
35. JE Tate, CA Panozzo, DC Payne Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine Pediatrics 124 2009 465 471
36. M Ali, M Emch, L von Seidlein Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis Lancet 366 2005 44 49
37. WHO Meeting of the immunization Strategic Advisory Group of Experts, April 2009 - conclusions and recommendations Wkly Epidemiol Rec 84 2009 220 236
38. V Richardson, J Hernandez-Pichardo, M Quintanar-Solares Effect of rotavirus vaccination on death from childhood diarrhea in Mexico N Engl J Med 362 2010 299 305